Recognition of the strength of non-human primate models in investigating metabolic disorders has resulted in an expanded need for in vivo research techniques. We studied adipose metabolism in 10 baboons (13.0 &[plusmn] 4.2y, 29.5 &[plusmn] 5.5 kg). Part 1 evaluated the effect of different sedatives on the rate of appearance of plasma fatty acids (RaFFA), assessed using <SUP>13</SUP>C<SUB>4</SUB>-palmitate infusion (7 µmol/kg/min). Animals, were studied with no sedation, with complete isofluorane sedation, and with minimal midazolam infusion (0.04 mg/kg/hr), with the latter scheme allowing for the most consistent values and animals that were visually more calm. Part 2: RaFFA and RaGlycerol (d<SUB>5</SUB>-glycerol, 5 mg/kg LBM/hr) were measured.
INTRODUCTION
Nonhuman primates, particularly Old World monkeys, have proven to be valuable models for the study of a variety of complex diseases and physiological processes expressing a pattern of susceptibility and complications similar to that seen in humans (1) . The close evolutionary relationship between humans and nonhuman primates suggest that they share many of the specific genetic mechanisms involved in determining differential susceptibility to disease (1) .
Not only do nonhuman primates offer a large, long-lived animal for the study of chronic diseases associated with metabolic dysregulation (4, 5) , they provide a model that is physiologically and genetically very similar to humans. The primary energy reserve in mammals is stored as adipose triacylglycerols (TG), and the release of that energy through the process of lipolysis is a metabolic event of great importance to the maintenance of health. Lipolysis is found to be dysregulated in disease (2, 3) and when the kinetics of both FFA and glycerol are measured in plasma, the ratio of these turnovers has been used as a means to estimate intra-adipocyte reesterification (4-6). To our knowledge, such methodology has not been developed for use in the baboon and if available, these techniques would allow the strengths of this animal model in genetic studies, to be extended to translational research in the area of obesity and metabolic disease. Accordingly, the objective of the present work was to optimize human (7) and rodent (8) protocols to establish clinical procedures for the measurement of blood fatty acid and glycerol fluxes in vivo in Papio hamadryas species. Using an established tether system (9), we modified a meal-feeding paradigm, and refined protocols for animal acclimation, to reduce stress and maintain the animals' body weights in the clinic. In addition, we present data showing the effects of different management techniques (anxiolytic treatment, sedation), how numerous variables can be measured using the minimum amount of blood, and document for the first time, by guest, on September 9, 2017 www.jlr.org
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METHODS
The baboons studied herein were selected from a population at the Southwest Primate Research Center (SNPRC) under study at the Texas Biomedical Research Institute (San Antonio, TX).
The protocol was approved by the Southwest Foundation for Biomedical Research Institutional
Animal Care and Use Committee (protocol # 1203PC 0). Animals were baboons (Papio hamadryas Sp.) >6 years of age (i.e., fully sexually mature) housed individually during the duration of their studies in cages with access to a light cycle from the room lights in the clinic, set to be on every day from 0600 to 1800. Using an established tether catheter system (9) , this project was conducted in two parts: In Part 1, the two females and 1 male baboon were selected using body weight criteria deemed normal for adults (females: 14-20 kg; males: 25-30 kg; unpublished SNPRC observations). Here we evaluated the effect of different anxiolytic doses of the benzodiazepine-agonist midazolam on the rate of appearance of fatty acids in plasma (RaFFA) in the 3 animals. Each animal was tested twice with an identical infusion of [1,2,3,4 -13 C 4 ]-hexadecanoate administered at 7µg/kg/min, complexed to human albumin in a ratio of 2:1.
The use of sedatives were varied between the two tests. The first animal (ID #11597) was studied once without the administration of the anxiolytic compound, and once with midazolam administration beginning at 2245 h with 0.025 mg/kg bolus given over a 2 min period, followed by a continuous infusion of 0.010 mg/kg/hr. Isotope infusion and blood drawing occurred through the tether catheters. The second animal (ID #11953) was studied under two doses of midazolam: dose #1 was a 0.025 mg/kg bolus starting at 2245 and given over a period of 2 min, followed by a continuous infusion of 0.020 mg/kg/hr; and dose #2 was a bolus of 0.025 mg/kg, started earlier at 1900, followed by a higher continuous infusion of 0.040 mg/kg/hr. The third animal (ID #11044) was studied under the higher anxiolytic dose of midazolam beginning at by guest, on September 9, 2017 www.jlr.org Downloaded from 1900 and then under complete isofluorane sedation, given as an inhalant (1.5% v/v gas). The isoflurane was tested because previous studies in dogs have shown isoflurane to reduce fatty acid release (12) . The repeat studies in animals were conducted on average, 19.3 ± 11.6 days apart to allow for decay of the isotopes.
In Part 2 of the project, as a result of the data generated in Part 1, we chose the higher dose of midazolam, beginning at 1900 and expanded data collection to include measurement of plasma glycerol turnover (RaGlycerol) as RaFFA and RaGlycerol are both indicators of adipose lipolysis. The seven males studied in Part 2 were chosen to represent a range of body weight so that the group would contain animals with large variation in adiposity and insulin sensitivity, as previously demonstrated by our group (13) . The baboons were admitted to the clinic and allowed to acclimate. During this time, each animal was observed for aggressive-submissive behaviors, daily food consumption was monitored, and the animal was acclimatized to the tether jacket system (9) . When acclimation was achieved, the animal underwent ketamine sedation and baseline assessments were made as follows: body composition by dual-energy X-ray absorptiometry scan (DEXA, Lunar Prodigy whole body scanner; GE Medical Systems, Madison, WI), measurements of body weight, waist circumference and body surface area, and blood sampling for clinical biochemistries. For DEXA, animals were placed in the supine position on the bed and the extremities were positioned within the scanning region. Scans were analyzed using Encore2007 software (v.11.40.004, GE Healthcare, Madison, WI). A euglycemic, hyperinsulinemic clamp study was performed the same day using previouslypublished methods (14) . Following these assessments, the animal underwent surgical tether implantation, as described in detail previously (9) . Catheter implants in the femoral artery and by guest, on September 9, 2017 www.jlr.org Downloaded from vein for tether were prepared as follows: Heparin (low molecular weight)-coated polyurethane (7 Fr) catheters were placed in the femoral artery and vein by laparotomy. An incision was made over the femoral artery and vein just below the inguinal lymph node and the femoral artery/vein and the profundus artery/vein were exposed by blunt dissection. Through a small incision in the profundus artery/vein, a catheter was introduced. The catheter was advanced through the profundus artery/vein into the femoral artery/vein. Both catheters were routed subcutaneously to the midscapular region of the back where they exited the skin into a molded plastic box (backpack) attached to the tether jacket. At the end of the study the tether catheters were removed by another surgery. During the 24-h occurring after catheter placement, the animal was carefully monitored and after recuperation over a period of 10 days, the stable isotope study was performed. Since the isotope infusion studies were planned to be performed at night, the veterinary technicians assigned to the project were exposed to the animals on a daily basis during the 3-wk acclimation period, including entering to the room at night to have the animals get accustomed to them doing so. Also, throughout the acclimation period, and during and in between the catheter placement and isotope infusion, food intake was measured daily. Body weight was monitored weekly and food intake was adjusted downward for increases in body weight. If body weight began to fall, additional enrichments (fruits, vegetables) were added.
Changes in an animal's behavior (e.g., depressive posture, interactions with handlers) were monitored by technical staff.
Dietary intake and isotope study
For all animals, food was made available from 0800 through 1600 each day. This protocol was followed to ensure that during fed-state measurements (made in the morning), all animals would by guest, on September 9, 2017 www.jlr.org Downloaded from be actively eating, and that during fasted-state measurements (through the night between 2300 and 0700), animals would be approaching a standardized fasted state. The baboons were acclimatized to this feeding regimen during the preparatory phases of this work (i.e., during the 3-wk duration of clinic and tether jacket acclimation and surgery recovery). The quantity of food offered to each baboon daily was based on the estimated metabolizable energy (ME) requirements for adult captive baboons. Specifically, the animals were fed a commercial diet targeted to meet an expected energy requirement to sustain constant body weight 40-51 kcal * BW (kg) (167-213 kJ) (15 Isotope Laboratory (Andover, Massachusetts, USA) and were sterile and pyrogen free, and were prepared using sterile techniques. Isotopic purity was greater than 98% for all the tracers used.
Analysis of blood metabolites
All blood samples were of 5 ml in volume and were drawn into chilled tubes containing EDTA; plasma was separated immediately by centrifugation (3000 rpm, 1500 x g, 10 min) at 4°C. The samples were kept on ice while benzamidine, gentamicin sulfate, chloramphenicol, phenylmethylsufonyl fluoride and trolox were added as preservatives (19) . TG-rich lipoproteins (TRL) with d < 1.006 g/L were isolated from plasma by ultracentrifugation as described previously (20) . The top 2 ml containing TRL were removed by tube slicing and the infranatant used to isolate FFA and glycerol for analysis by GC/MS (16). On a separate day from all other tests, blood for serum cortisol concentrations was drawn at 0700, 1030, 1400, and 1630 and and FFA (WAKO, #999-34691, #991-34891); insulin was measured by ELISA (Millipore, #EZHI-14L), and TRL-apoB100 by a human total apoB100 kit (Kamiya Biomedical Co, Seattle, WA). TRL-apoB48 concentration was measured using a human apoB48 ELISA kit (Shibayagi, Inc). Sufficient TRL samples were available in 8 out of 10 animals for the measurement of these apolipoproteins and in 1 animal, the concentration of apoB48 was 10-fold that of the other animals. Since a cross reacting protein was suspected, this animal's values were excluded from the analysis. Results of these assays were all read on a Power wave XS micro-titer plate reader (Biotek, Inc).
Analysis of fatty acids and glycerol
The fatty acid composition of plasma FFA was analyzed on a HP 6890 series gas chromatograph (GC) using a SP TM -2560 fused-silica capillary column (100m x 0.25mm i.d., 0.020µm film;
Supelco Inc., Bellefonte, PA) and equipped with a flame ionization detector (Hewlett-Packard, Palo Alto, CA). The temperature was programmed at 140°C for 5 min, followed by an increase of 4°C/min to reach a final temperature of 240°C and then held for 50 min. The injector was operated in the split-less mode and was kept at 260°C. Individual fatty acids were identified by retention time in comparison to known standards. For fatty acid isotopomer analysis by GC/MS, we used a 6890N gas chromatograph coupled to a 5975 mass selective detector (Agilent Technologies, Palo Alto, CA). The GC/MS was equipped with an Agilent DB-225 fused silica capillary column (30-m x 0.25-mm inside diameter, 0.25µm film) with helium as a carrier gas flowing at the rate of 1.5 ml/min. The initial temperature was 75°C, which then rose to 220°C at a rate of 40°C/min, followed by a rise to 230°C at a rate of 5°C/min. The final temperature was held constant for a total run time of 14.75 min. The injector was operated in the split-less mode and kept at 230°C. The GC/MS method utilized selected ion monitoring for m/z of 270 and 274.
Palmitate methyl ester enrichments were calculated using 5-point standard curves for M4
analysis and the average steady-state M4 % enrichment was 3.00 ± 1.37%. For plasma glycerol enrichments, a DB-17 ms, 30m column was used (0.25 mm ID, 0.25 m phase thickness) with a split-less injection and GC conditions as follows: 70ºC for 1 min, then temperature was ramped at 20ºC/min to 220ºC, held for 2 min, ramped at 30ºC/min to 280ºC and held for 2 min. The total run time was 14.5 min (21). The injector temperature was 250ºC, transfer line: 280ºC, source:
230ºC, quadrapole: 150ºC, with helium as the carrier gas flowing at a constant rate of 1 ml/min.
Isotopomers of the propionic ester of glycerol (m/z 171, 172, 173, 175, 176) were assessed in the 
Calculations and statistical analysis
The fatty acid infusate composition and enrichments were analyzed by GC and GC/MS, and the calculations of the rate of appearance of fatty acids (RaFFA) were adjusted for the amount of unlabeled fatty acids present in the FFA pool that were derived from less than 100% purity of the isotope and fatty acids present on the albumin used in the infusion. RaGlycerol was calculated as described by Wolfe (7 Then, this number for each animal was average to obtain the group mean presented in the table.
To calculate the theoretical adipose fatty acid intracellular re-esterification rate, for each animal, the ratio of RaFFA to RaGlycerol was calculated, then this value was subtracted from 3.0 (the theoretical maximal ratio of release rates of FFA and glycerol from adipose-TG) to get the difference. This difference was then divided by 3.0 to estimate the percentage of fatty acids released from intracellular lipolysis that did not appear in the plasma compartment. Calculations were carried out using Excel (version 2007; Microsoft, Seattle, WA).
RESULTS
The clinical and laboratory values displayed in table 2 reflect characteristics of adult baboons.
Concentrations of total cholesterol, TG, and insulin were normal. Glucose disposal rates 2F) were observed under isoflurane sedation compared to midazolam. We learned from this work that the use of midazolam gave similar steady-state concentrations and turnovers between 0600 and 0700, and importantly, resulted in more calm behavior in the animals. As a result of these studies, we chose a protocol utilizing a midazolam bolus, 0.025 mg/kg, which was started at 1900, followed by a continuous infusion of 0.040 mg/kg/hr.
In Part 2 of this research, the animals were acclimated to food availability between the hours of 0800 and 1600 to aid in the measurement of both fed and fasting metabolism. This protocol for monitoring and managing food intake resulted in tight control of body weights (suppl. fig. 1 ).
From the date of sham tether, through surgery and recovery after tether placement, to the date of the metabolic infusion, the animals did not lose weight and only gained 0.33 ± 0.59 kg. Fig. 3 shows the blood metabolite concentrations during the isotope infusion tests. The expected temporal patterns of metabolites were observed -e.g., after initiation of food consumption, the time-to-peak of glucose concentration was 4 hrs and glucose concentrations remained relatively steady throughout the night and fell off after 0400 ( fig. 3A) . Concentrations of total plasma-TG ( fig. 3B) and that in the TG-rich lipoproteins (chylomicrons and VLDL, fig. 3C ), along with TRL-apoB48 ( fig. 3D ) rose steadily during the first 5 hrs of food intake. TRL-apoB100
concentration fell between 0800 and 1300 ( fig. 3C) . Throughout the day, TRL-TG represented 17-35% of plasma-TG, a ratio lower than the 37-67% observed in humans (E. Parks, unpublished). During the night, concentrations of plasma-TG, TRL-TG, TRL-apoB100, and TRL-B48 rose to peak between 0200 and 0400 and then returned to baseline at 0600. The TRLapoB48 concentrations rose and fell in a pattern similar to the TRL-TG and apoB100
concentrations suggesting that the elevation in TRL-TG observed between 0200 and 0400 was partially due to the presence of chylomicrons in plasma ( fig. 3C) . Serum cortisol concentrations were measured at 4 time points on a single day (suppl. fig. 2) . The values were within normal ranges and revealed typical circadian levels that fall throughout the day (22) . These data suggest that the use of an acclimation phase successfully adapted the animals for study.
Day-long changes in plasma FFA and glycerol concentrations (fig. 4A ) demonstrated a similar postprandial pattern as the TG concentrations -rising as the animal began to eat. However, night-time values, between 2300 and 0400, rose to levels found earlier in the day (1300). The night-time peak occurred between 0100 and 0200, and then values fell toward morning.
Between animals, FFA and of glycerol concentrations were variable, yet, within a given animal, the changes in concentrations of FFA and glycerol mirrored one another. Shown in fig. 4B are the turnover data for FFA and glycerol from 2300 to 0700 (i.e., during the time of the isotopic infusions). The calculated values of appearance start higher for the first 2 hrs of the night because the FFA and glycerol pools have not sufficiently turned over to reach steady state. After 0100 in all animals, the turnover rates of both metabolites approached a steady-state, which was achieved fully at 0600. Again, the shapes of the FFA and glycerol turnover curves paralleled one another. The mean rate of appearance of FFA (RaFFA) in the baboons at steady state (table 3) was 39.4 ± 29.8 mol/kgFM/min and RaGlycerol was 26.9 ± 7.3 mol/kgFM/min. The ratios of FFA to glycerol turnover rates averaged 1.5 ± 0.8 and thus, it was estimated that 49.3 ± 25.1% of fatty acids were re-esterified before leaving the adipose tissue. Baseline correlations between FFA turnover rates and body fat composition were explored to allow comparison to data available in humans. Negative correlations were found between the RaFFA and measures of body fat (suppl. fig. 3 ), either per kg fat mass (r=0.699, P=0.024, a relationship that may also be curvilinear), or waist circumference (r=0.658, P=0.039). In other words, those animals with the highest quantities of body fat had the lowest fatty acid appearance rates in plasma.
DISCUSSION
The objective of the present work was to modify and optimize human (7) and rodent (8) protocols to establish clinical procedures for the measurement of blood fatty acid and glycerol fluxes in vivo in a non-human primate model. In order to obtain baseline data to assess the animals' recoveries after implantation of the tether catheter, we first carefully monitored the food intakes and body weights of animals as they were housed separately in cages in the clinical unit.
Food is routinely delivered once per day, in the morning. We found the natural timing of food intake to vary widely among the animals throughout the day. As is well appreciated by veterinary staff, most baboons would consume the daily ration of food during the daylight hours, but some animals would eat all of it beginning immediately when it was presented, while others would spread out their intake throughout the 24-hr period. Acclimating the animals to a regimen of food availability between 0800 and 1800 allowed the animals to adjust to consumption of all their food during this period and, within an hour of the food's arrival in the morning, all animals were seen to be actively eating. We have used a similar protocol in mice previously (23) and the result is that blood draws could be timed specifically to test postprandial metabolism in the morning and that studies performed at night would assess the animal's metabolism as it transitioned to the fully-fasted state the next morning (i.e., avoiding active night-time eating). In human studies of fatty acid turnover, research subjects are frequently asked to fast for long periods of time so that metabolism can be measured in a steady state (16, 24) . To achieve this same end in the baboon, we did not feel we could restrict food for a lengthy period because it would result in a situation disadvantageous for both the animal (under stress) and the research (erratic and varying metabolic states between animals). The blood draws planned at night necessitated a technician entering the room containing the cage and the use of midazolam is a by guest, on September 9, 2017 www.jlr.org
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limitation of this study, in that it may have some unforeseen physiologic effects. However, the low-dose infusion of the drug midazolam, with its anxiolytic effects, allowed us to perform the overnight isotope infusions with less recorded stress to the animal and steady levels of metabolites. From these blood samples, lipoprotein particles were isolated and the plasma FFA and glycerol molecules were extracted from the infranatant. This methodology maximized the number of metabolites that could be analyzed using the minimum amount of blood drawn at each time point. Thus, the final protocol developed during the method development phase demonstrated maintenance of food intakes and body weights, limited the stress on the animal, and allowed sufficient blood sampling to achieve measurements of glucose, insulin, cortisol, plasma-TG, TRL-TG, apolipoproteins, FFA, and glycerol concentrations and the turnover of these latter metabolites as well.
The long-term energy reserve in mammals is stored as adipose TG, and the release of that energy through the process of lipolysis is a metabolic event of great importance to the maintenance of health. Lipolysis is found to be dysregulated in disease (2, 3). When both FFA and glycerol turnovers are measured, the ratio of plasma FFA to glycerol turnovers has been used as a means to estimate intra-adipocyte re-esterification (4-6). There are clear limitations to assumptions at the basis of these calculations, including the potential for adipocyte glyceroneogenesis (25) , the fact that fatty acids and glycerol from dietary-TG breakdown contribute to the plasma FFA or glycerol pools (26) , and lack of information on the activities of intracellular acyltransferases which may allow some diacylglycerol or monoacylglycerol species to reform TG (intracellular recycling) such that total lipolytic rate is not measureable based on observation of turnover of plasma pools (27) . Nonetheless, in vivo calculations of lipolysis and re-esterification have provided important data to expand the understanding of mechanisms of many diseases, including that of body mass wasting (28) , the impact of smoking on adipose metabolism (29) , and the effects of acute exercise on energy balance (30) , to name a few. Recent recognition has also been made as to the advantages of studying non-human primates to understand metabolic diseases (1, 13, 14) . Given intense focus on the role of adipose tissue-mediated insulin resistance in the development of obesity and type 2 diabetes Secondly, this study documented that the turnover of FFA and glycerol do not come to steady state until morning, a fact also recently recognized in humans (10) . In the present protocol, which provides ad libitum food intake during 8 daylight hours, and no food availability after 1600, the baboon's fatty acid and glycerol concentrations peaked in the middle of the night and then slowly approached a fasted value between 0500 and 0600. The appearance rates into plasma also became stable at this time allowing for accurate kinetic appearance and disappearance rates to be calculated. Our third finding, a rate of appearance of FFA of 39.4 ± 29.8 mol/kgFM/min, is a value slightly faster than that observed in healthy, lean humans of ~ 28 µmol/kg FM/min (4, 16) . RaGlycerol in the baboons was 26.9 ± 7.3 mol/kgFM/min, which appears significantly higher than that reported for humans -averaging 7.3 mol/kgFM/min, with a range of 6.2 to 21.0 (4, 5, 38). We present individual data for animals because, to our knowledge, studies of this kind have not been attempted before in the baboon. The RaFFA turnover data demonstrate peaks and valleys during the early morning hours and we see similar nocturnal variability in human (EJ Parks, unpublished observations). These data alone might suggest the variances could be due to technical factors, however, the level of enrichments achieved during the isotope infusions were well within the range for accurate detection. Further, the patterns of RaGlycerol data mirrored the RaFFA well and the curves of FFA and glycerol concentration also vary in parallel. These observations support the concept that our findings represent true physiologic flux. This concept is also strengthened by the fact that the measurements of the metabolites were made independently, using different plasma extraction procedures, derivatization reagents, and separate GC/MS analysis protocols. Thus, the increasing and decreasing fluxes observed here are likely due to circadian rhythm in the baboon.
The precise metabolic control systems that resulted in a rise in TRL-TG, apoB, FFA, and glycerol between midnight and 0500 will be important to determine in future studies.
Lastly, the ratio of FFA to glycerol turnover rates at steady state was 1.5 ± 08, and thus it was estimated that 49% of fatty acids were re-esterified before leaving the adipose tissue. These data are slightly higher than the average taken from human literature -34%, (4, 5, 39) but fall within the range reported in these studies (17-56%). We also found that animals with the greatest fat mass demonstrated the lowest fatty acid release rates -an observation also found in humans (40).
These data add support for the use of this animal model to investigate metabolic dysregulation.
In summary, we present a detailed protocol for the measurement of adipose substrate flux in the baboon and to our knowledge, these are the first data to document these fluxes in this animal, demonstrating nocturnal patterns of metabolism. These methods will support needed research to determine how adipose insulin resistance predisposes to the development of chronic diseases using the overweight baboon as a model. Such studies will allow testing of the in vivo mechanisms by which weight loss and pharmacologic treatments can aid in the treatment of metabolic disorders (11) . figure 3 ). Animals were acclimated to food availability between 0800 and 1600. Blood was drawn through the tether system catheter periodically during the day and night. Stable isotope infusions were performed starting at 2300 and continued until 0700. Isotope infusion and blood drawing occurred through the tether catheter. For details of feeding and animal management protocols, please see the Methods Section.
FIGURE 2. Effects of +/-midazolam treatment and complete/no sedation
Data are presented for 3 animals with night-time plasma FFA concentrations in the graphs on the left (fig. A, C, E ) and FFA turnover rates in the graphs on the right (fig. B, D, F) . See  table 1 for details of interpretation. Representative data from plasma concentrations of FFA and glycerol (A) and turnover over rates (B) in three animals that had infusions of stable isotopes of fatty acid and glycerol from 2300 to 0700. The individual animal's identification number is in the upper left hand corner of each graph.
